The SARS-CoV-2 / Influenza A/B / RSV rapid test is a rapid diagnostic test (RDT) for professional use only, allowing the detection of Influenza A/B + COVID-19 + RSV by performing a single sample collection on a patient.
✓ Cover a wider range of respiratory viruses in a single test
✓ Easy to use, results in 10 minutes maximum
✓ Nasal or nasopharyngeal swab
✓ Test listed on the EU common list of antigen detection tests for COVID-19 diagnosis (Page 61): Common list
| Reference | TES-H107 | |
Product sheet | ||
Statement ofcompliance THIS | ||
Noticed‘use(FR) | ||
Report ofevaluation Clinical Performance (EN) | ||
Packaging | 20 Kits per box, 48 boxes per carton // 960 Kits per carton 560*460*460mm, 22kg/carton | |
Contents of the box | 20 x test cassettes (Triple Result Reader) 20 x sterile swabs 20 x prefilled extraction tubes with buffer solution 1 x Workstation 1 x Instruction manual | |
Dataclinics | SARS-CoV-2 antigen | Clinical sensitivity: 95.00% Clinical specificity: 99.75% |
Influenza A/B antigen | Clinical sensitivity: 93.02% Clinical specificity: 97.26% | |
RSV antigen | Clinical sensitivity: 94.12% Clinical specificity: 97.87% | |
*Given the current regulations, the collection of nasopharyngeal samples for antigen tests is entrusted to doctors, pharmacists, state-certified nurses, as well as other healthcare professionals (See the PDF document - Other_Healthcare_Professionals_authorized according to art.25 / Decree of 10.07.20).
